` 3401 (Teijin Ltd) vs Nikkei 225 Comparison - Alpha Spread

3401
vs
Nikkei 225

Over the past 12 months, has outperformed Nikkei 225, delivering a return of -4% compared to the Nikkei 225's 7% drop.

Stocks Performance
3401 vs Nikkei 225

Loading
3401
Nikkei 225
Add Stock

Performance Gap
3401 vs Nikkei 225

Loading
3401
Nikkei 225
Difference

Performance By Year
3401 vs Nikkei 225

Loading
3401
Nikkei 225
Add Stock

Competitors Performance
Teijin Ltd vs Peers

Nikkei 225
3401
2010
TPIA
PTPIF
DOW
Add Stock

Teijin Ltd
Glance View

Market Cap
260.9B JPY
Industry
Chemicals

Teijin Ltd., a venerable name in the realms of material innovation and technology, traces its roots back to the early days of the 20th century in Japan. Starting as a textile manufacturing company, Teijin has metamorphosed into a multifaceted conglomerate with a global footprint. Today, Teijin's operations span numerous sectors, including high-performance fibers, healthcare, films, resin, and plastics processing. This strategic diversification allows the company to remain nimble and resilient in the face of changing market dynamics. At the core of Teijin's success is its incessant focus on leveraging cutting-edge technology and research to develop materials that cater to crucial industries such as aerospace, automotive, and healthcare. By consistently pushing the boundaries of innovation, Teijin crafts solutions that not only meet the stringent demands of these sectors but also forge new paths towards sustainable and eco-friendly practices. A key driver of Teijin's revenue generation strategy is its ability to integrate its various divisions seamlessly, creating synergies across its diverse product lines. This integration is evidenced by its pioneering work in developing carbon fiber composites, which are instrumental in reducing weight and improving fuel efficiency in the automotive industry. Furthermore, Teijin's healthcare division capitalizes on the growing demand for advanced medical and pharmaceutical products. By offering hemofiltration and plasma exchange solutions, among others, the company addresses critical health issues and contributes to the well-being of aging populations globally. The interplay of these industries within Teijin's portfolio not only enhances its market reach but also fortifies its financial robustness. Teijin's proficiency in balancing innovation with pragmatic industrial applications underscores its enduring prominence and success in a competitive global landscape.

Intrinsic Value
2 326.5 JPY
Undervaluation 42%
Intrinsic Value
Price
Back to Top